Novo Nordisk

TrumpRx — the government’s drug pricing initiative, which is at the center of the tariff deals the administration has reached with drugmakers since September —...

Technology How Roche Hopes To Go Toe-To-Toe With Eli Lilly, Novo Nordisk In Obesity Licensing Roche (RHHBY) hopes to go toe-to-toe with Eli Lilly (LLY) and Novo...

European pharmaceutical company Novo Nordisk (NVO) is spending twice as much as its U.S. rival Eli Lilly on weight-loss drug advertisements. Data from advertis...

If you are wondering whether Novo Nordisk's current share price still offers value, this article will walk through what the numbers say about the stock today....

Citi initiated coverage of Novo Nordisk (NVO) with a Neutral rating and DKK 400 price target The firm views the stock’s valuation as appropriate at current shar...

This pharmaceutical giant has recently caught fire, and the stock's run is likely just beginning. Novo Nordisk (NVO +2.70%) essentially made the obesity drug m...

Novo Nordisk (NYSE:NVO) has launched the first FDA approved oral GLP-1 weight loss drug, a Wegovy pill, with very strong initial prescription uptake. The compa...

Advertisement What Novo Nordisk’s recent performance data tells you Novo Nordisk (NYSE:NVO) has posted mixed return figures, with the share price roughly flat...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. The VanEck Pharm...

Danish drugmaker Novo Nordisk’s (NVO) shares rose about 3% as data showed that over 18,000 prescriptions were issued in the first week of the launch of the Wego...